BioFilm Manufacturing Facility granted MHRA Licence

BioFilm Limited announced today that its Manufacturing Facility at Blantyre has been licensed by the Medicines and Healthcare products Regulatory Agency (MHRA) for the commercial manufacture of pharmaceutical thin dissolving films including herbal products following a very successful inspection of the facility carried out by the MHRA Good Manufacturing Practice (GMP) Inspector. This is in addition to the currently held Manufacturing Authorisation for Investigational Medicinal Products MIA (IMP), which permits the manufacture of Medicinal Products for use in Clinical Trials.

BioFilm Limited is a world leader in the development of thin dissolvable film products for applications in food, medical devices, cosmetic and pharmaceutical delivery. This achievement represents a major milestone in the development of BioFilm Limited and the progression of the company to becoming the worldwide Contract Manufacturer of choice, for those wishing to manufacture dissolvable films containing active ingredients.